Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
ABP 692 vs Ocrelizumab for Multiple Sclerosis
Recruiting2 awardsPhase 3
Carlsbad, California
This trial aims to show that ABP 692 is similar to Ocrelizumab in terms of how the body processes the drug and how it affects the brain. The study will compare the
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.